The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Eflapegrastim, a novel and potent long-acting GCSF for reducing chemotherapy-induced neutropenia: Integrated results from two phase III trials in breast cancer patients.
 
Lee S. Schwartzberg
Stock and Other Ownership Interests - Vector Oncology
Honoraria - Amgen; E.R. Squibb Sons, LLC; Genentech; Helsinn Healthcare; NanoString Technologies; Napo Pharmaceuticals; Novartis; Pfizer; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Caris Life Sciences; E.R. Squibb Sons, LLC; Genentech; Genomic Health; Helsinn Therapeutics; Lilly; Novartis; Pfizer; Roche; Spectrum Pharmaceuticals; Tesaro; Vector Oncology
Research Funding - Amgen (Inst); Bayer Health (Inst); E.R. Squibb Sons, LLC (Inst); E.R. Squibb Sons, LLC (Inst); Genentech (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); Tesaro (Inst)
 
Gajanan Bhat
Employment - Spectrum Pharmaceuticals
Stock and Other Ownership Interests - Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Spectrum Pharmaceuticals
 
Jayaram S. Bharadwaj
No Relationships to Disclose
 
Osama Hlalah
No Relationships to Disclose
 
Alvaro Restrepo
No Relationships to Disclose
 
Inderjit Mehmi
Speakers' Bureau - Array BioPharma; Bristol-Myers Squibb
 
Shanta Chawla
Employment - Spectrum Pharmaceuticals
Stock and Other Ownership Interests - Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Spectrum Pharmaceuticals
 
Patrick Wayne Cobb
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Amgen; Boston Scientific; crispr therapeutics; Intuitive Surgical; Johnson & Johnson; Medtronic; Merck; Pfizer (I); Siemens; Thermo Fisher Scientific; United Health Group
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); EMD Serono (Inst); Galera Therapeutics (Inst); Genentech/Roche (Inst); GTx (Inst); Incyte (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Pharmacyclics (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst); TG Therapeutics (Inst); United Therapeutics (Inst)